InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Hastings David C, Director. Director active across 3 companies, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 11 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €71k. History available since 18 January 2022. The latest transaction was disclosed on 26 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
David C. Hastings is a Director at Entasis Therapeutics Holdings Inc. and SCYNEXIS INC. In this role, he participates in the strategic decisions of these companies and ensures good governance. His experience in the biopharmaceutical sector allows him to provide valuable insights during board discussions.